Phases of DSS development and validation.

<p>Phases of DSS development and validation.</p

DSS screenshot showing the “rules” and DSS engine logic based on 2007 Indian Hypertension II guidelines for drug management.

<p>DSS screenshot showing the “rules” and DSS engine logic based on 2007 Indian Hypertension II guidelines for drug management.</p

DSS screenshot showing staging of hypertension, risk category, and tailor made recommendations for drug treatment, pharmacological indication and contraindications, lifestyle support and follow up advice.

<p>DSS screenshot showing staging of hypertension, risk category, and tailor made recommendations for drug treatment, pharmacological indication and contraindications, lifestyle support and follow up advice.</p

DSS screenshot showing “rules” and DSS engine logic based on 2007 Indian Hypertension II guidelines for risk staging.

<p>DSS screenshot showing “rules” and DSS engine logic based on 2007 Indian Hypertension II guidelines for risk staging.</p

Subgroup analyses for the association between serum uric acid and incident prediabetes and incident type 2 diabetes mellitus.

<p>Subgroup analyses for the association between serum uric acid and incident prediabetes and incident type 2 diabetes mellitus.</p

The association between serum uric acid and incidence of prediabetes and type 2 diabetes mellitus.

<p>The association between serum uric acid and incidence of prediabetes and type 2 diabetes mellitus.</p

Quartile-specific hazard ratios for serum uric acid in association with incident prediabetes and incident type 2 diabetes mellitus.

<p>Quartile-specific hazard ratios for serum uric acid in association with incident prediabetes and incident type 2 diabetes mellitus.</p

Selection of the study population.

<p>Selection of the study population.</p

P-values for the associations of the 18 CRP SNPs with different cardiometabolic phenotypes.

<p>P-values for the associations between the 18 CRP SNPs and BMI, lipids, glycemic phenotypes, SBP and coronary artery disease. The genes on the x-axis represent the genes in which the CRP SNPs are located or closest by. The numbers on the y-axis indicate the p-values of the association between the SNPs and the cardiometabolic phenotypes. Significant associations are colored as depicted in the figure legend. For BMI and SBP, no significant associations were observed. CAD, coronary artery disease; FG, fasting glucose; FI, fasting insulin; HDLC, HDL-cholesterol; LDLC, LDL-cholesterol; T2D, type 2 diabetes; TC, total cholesterol; TG, Triglycerides.</p

Assessment of study quality through the Newcastle-Ottawa Scale.

<p>Assessment of study quality through the Newcastle-Ottawa Scale.</p